文献速递胃肠外科围术期管理与 ERAS

第三次抗反流手术:胸腹入路患者报告结局

Third-time ("redo-redo") anti-reflux surgery: patient-reported outcomes after a thoracoabdominal approach.
PubMed 文献 · Surg Endosc · 2019-08-06

该回顾性研究纳入1999至2017年间至少接受第二次修正抗反流手术的18例成人,评估第三次(redo-redo)手术后的生活质量和围术期并发症。完成问卷的10例中8例反流缓解、6例反流症状缓解,4例仍需PPI。开放胸腹入路在合适选择的患者中并发症低且生活质量结果良好。

要点

  • 第三次抗反流手术在严格选择患者中可行,开放胸腹入路占多数。
  • 术后无死亡,72%患者无并发症,但再手术指征多为反流、反流和吞咽困难。
  • 完成QoL问卷者中多数反流和反流症状缓解,部分仍需PPI。

核心结论

  • 对于需要第三次抗反流手术的合适患者,开放胸腹入路并发症低且生活质量结果良好。

研究设计与样本

  • 回顾性研究纳入1999至2017年间至少接受第二次修正抗反流手术的成人,共18例(13例有2次既往手术,5例有3次既往手术),中位随访6年(IQR 3,12)。

主要发现

  • 无死亡,13/18例(72%)无术后并发症。
  • 10例完成生活质量问卷,8例反流缓解,6例反流症状缓解,4例仍需质子泵抑制剂(PPI)。
  • SF36各维度平均分:生理功能79.5(±19.9),生理角色限制52.5(±46.3),情感角色限制83.3(±36.1),活力60.0(±22.7),情感健康88.4(±8.7),社会功能75.2(±31.0),疼痛66.2(±30.9),总体健康55.0(±39.0)。

临床怎么用

  • 对多次抗反流手术失败的患者,第三次修正手术可考虑开放胸腹入路,但需严格选择患者并告知术后部分患者仍需PPI。

局限性

  • 样本量小(18例),仅10例完成生活质量问卷,为回顾性单中心经验,随访中位6年但部分患者失访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Approximately 3-6% of patients undergoing anti-reflux surgery require "redo" surgery for persistent gastroesophageal reflux disease (GERD). Further surgery for patients with two failed prior anti-reflux operations is controversial due to the morbidity of reoperation and poor outcomes. We examined our experience with surgical revision of patients with at least two failed anti-reflux operations. METHODS: Adults undergoing at least a second-time revision anti-reflux surgery between 1999 and 2017 were eligible. The primary outcomes were general and disease-specific quality-of-life (QoL) scores determined by Short-Form-36 (SF36) and GERD-Health-Related QoL (GERD-HRQL) instruments, respectively. Secondary outcomes included perioperative morbidity and mortality. RESULTS: Eighteen patients undergoing redo-redo surgery (13 with 2 prior operations, 5 with 3 prior operations) were followed for a median of 6 years [IQR 3, 12]. Sixteen patients (89%) underwent open revisions (14 thoracoabdominal, 2 laparotomy) and two patients had laparoscopic revisions. Indications for surgery included reflux (10 patients), regurgitation (5 patients), and dysphagia (3 patients). Intraoperative findings were mediastinal wrap herniation (9 patients), misplaced wrap (2 patients), mesh erosion (1 patient), or scarring/stricture (6 patients). Procedures performed included Collis gastroplasty + fundoplication (6 patients), redo fundoplication (5 patients), esophagogastrectomy (4 patients), and primary hiatal closure (3 patients). There were no deaths and 13/18 patients (72%) had no postoperative complications. Ten patients completed QoL surveys; 8 reported resolution of reflux, 6 reported resolution of regurgitation, while 4 remained on proton-pump inhibitors (PPI). Mean SF36 scores (± standard deviation) in the study cohort in the eight QoL domains were as follows: physical functioning (79.5 [± 19.9]), physical role limitations (52.5 [± 46.3]), emotional role limitations (83.3 [± 36.1]), vitality (60.0 [± 22.7]), emotional well-being (88.4 [± 8.7]), social functioning (75.2 [± 31.0]), pain (66.2 [± 30.9]), and general health (55.0 [± 39.0]). CONCLUSION: An open thoracoabdominal approach in appropriately selected patients needing third-time anti-reflux surgery carries low morbidity and provides excellent results as reflected in QoL scores.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Panda N, Rattner DW, Morse CR, et al. Third-time ("redo-redo") anti-reflux surgery: patient-reported outcomes after a thoracoabdominal approach. Surg Endosc. 2019. PMID: 31388809. doi:10.1007/s00464-019-07059-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。